IPF Clinical Trial
Official title:
Turkish Validity and Reliability of the Saint George Respiratory Questionnaire Idiopathic Pulmonary Fibrosis Version (SGRQ-I)
The Saint George Respiratory Questionnaire (SGRQ) questionnaire is a frequently used questionnaire in the respiratory patient group, and the Turkish version of this questionnaire, which was created for use in idiopathic pulmonary fibrosis patients, is not available. There is no commonly used quality of life questionnaire in patients with idiopathic pulmonary fibrosis. The aim of the study is to translate and validate the SGRQ idiopathic pulmonary fibrosis version of questionnaire into Turkish.
- The study is a cross-sectional, questionnaire validation study. - It is planned to complete the study within 2 years after the sufficient sample size is reached and the evaluations are made. The study will be terminated when the sufficient number of patients is reached. - The main thing in the application of special tools such as questionnaires is to prove the usability of the tool in the sample group to which it will be applied. The first step for this is the translation phase from the original language to the other language. At this stage, it is ideal for people who know the structure of the target language and the original language well, who have a good command of these languages and who are experienced in doing the translation. In our study, two people who are fluent in the original language will translate the questionnaire into the target language and two different people will translate the original language again. - To the participants; Demographic Evaluation Form, Saint George's Respiratory Questionnaire (SGRQ), and SGRQ idiopathic pulmonary fibrosis version of Questionnaire (SGRQ-I) will be applied. The SGRQ-I questionnaire will be administered again one week after the first application date in order to determine the test-retest reliability. - Scale reliability will be tested with Cronbach Alpha.For construct validity, confirmatory factor analysis will be applied and confirmatory factor analysis will be applied. For content validity, opinions of different experts will be taken for each item, and the status of items in the scale will be determined according to the results obtained by substituting it. In the logical validity process; Coverage of the components constituting the measured skill for each item will be considered. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05570058 -
Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
Recruiting |
NCT02807025 -
Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases
|
N/A | |
Recruiting |
NCT05895565 -
A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects
|
Phase 1 | |
Completed |
NCT03211507 -
Idiopathic Pulmonary Fibrosis Job Exposures Study
|
||
Completed |
NCT02503657 -
Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
|
Phase 2 | |
Recruiting |
NCT03873298 -
Inhaled NO in IPF and COPD During 6 Minute Walk Test
|
Phase 2 | |
Terminated |
NCT03864328 -
A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF
|
Phase 2 | |
Completed |
NCT05803850 -
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058
|
Phase 1 | |
Withdrawn |
NCT05349760 -
A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
Completed |
NCT01266317 -
Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
|
Phase 1/Phase 2 | |
Completed |
NCT04503044 -
ILAs in CT Lung Cancer Screening Population
|
||
Recruiting |
NCT04564183 -
Advancing Prevention of Pulmonary Fibrosis
|
||
Recruiting |
NCT05190211 -
Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis
|
N/A | |
Recruiting |
NCT04263727 -
A Study of Patients With Chronic Disease
|
||
Completed |
NCT05353556 -
Effects of Home-based Inspiratory Muscle Training in Patients With IPF
|
N/A | |
Completed |
NCT02976935 -
Functional MR Lung Imaging Using Hyperpolarised 129Xe
|
||
Recruiting |
NCT05193136 -
Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease
|
||
Recruiting |
NCT06181370 -
Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF
|
Phase 1 | |
Not yet recruiting |
NCT02885961 -
The Coagulation Cascade in Idiopathic Pulmonary Fibrosis
|
N/A | |
Completed |
NCT02151435 -
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
|
N/A |